Health‐related quality of life in survivors of advanced melanoma treated with anti‐PD1‐based immune checkpoint inhibitors

Abstract Background Immune checkpoint inhibitors (ICIs) have significantly improved survival in advanced melanoma but are associated with immune‐related adverse events (irAEs). This single center, cross‐sectional survey aimed to describe the long‐term symptom burden and impact on health‐related qual...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	E. L. Looman, P. F. Cheng, J. Lai‐Kwon, L. Morgan, M. Wakkee, R. Dummer, F. Dimitriou
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2023-06-01
Sarja:	Cancer Medicine
Aiheet:	immune checkpoint inhibitors immunotherapy melanoma quality of life survivorship
Linkit:	https://doi.org/10.1002/cam4.5967
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!